RESUMO
BACKGROUND: Minimal access surgery (MAS) is well-established in urological surgery. However, MAS is technically demanding and associated with a prolonged learning curve. Robot-assisted laparoscopy has made progress in overcoming these challenges. OBJECTIVE: The aim of this study was to evaluate the feasibility of a new robot-assisted surgical system (the Versius Surgical System; CMR Surgical, Cambridge, UK) for renal and prostate procedures in a preclinical setting, at the IDEAL-D phase 0. DESIGN, SETTING, AND PARTICIPANTS: Cadaveric sessions were conducted to evaluate the ability of the system to complete all surgical steps required for a radical nephrectomy, prostatectomy, and pelvic lymph node dissection. A live animal (porcine) model was also used to assess the surgical device in performing radical nephrectomy safely and effectively. Procedures were performed by experienced renal and prostate surgeons, supported by a full operating room team. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Surgical access and reach were evaluated by the lead surgeon using a visual analogue scale. The precise surgical steps conducted to make the assessment that the procedures could be completed fully were recorded, as well as instruments used (including manual laparoscopic instruments) and endoscope angle. RESULTS AND LIMITATIONS: In total, all 24 procedures were completed successfully in cadavers by eight different lead surgeons. Positioning of the ports and bedside units reflected the lead surgeon's preferred laparoscopic set-up and enabled good surgical access and reach, as quantified by a median visual analogue score of ≥6.5. Radical nephrectomies performed in pigs were all completed successfully, with no device- or non-device-related intraoperative complications recorded. Testing in human cadavers and pig models balances the bias introduced by each model; however, it is impossible to completely replicate the experience and performance of the robot for surgery in live humans. CONCLUSIONS: This is the first preclinical assessment of the Versius Surgical System for renal and prostate procedures. The safety and effectiveness of the system have been demonstrated and warrant progressive assessment in a clinical setting utilising the IDEAL-D framework. PATIENT SUMMARY: In this report, we looked at the usability of a new robot-assisted surgical device for renal and prostate surgery by testing the system in cadavers and pigs. We found that a number of different surgeons and operating team personnel were able to use the system to successfully complete the procedures under evaluation. We conclude that the system is ready to be tested in live human studies.
Assuntos
Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Nefrectomia , Próstata/transplante , Prostatectomia , Procedimentos Cirúrgicos Robóticos/instrumentação , Robótica , Animais , Cadáver , Masculino , Nefrectomia/veterinária , Próstata/cirurgia , Prostatectomia/veterinária , Suínos , Procedimentos Cirúrgicos UrogenitaisRESUMO
In the prostate, stem and progenitor cell regenerative capacities have been ascribed to both basal and luminal epithelial cells. Here, we show that a rare subset of mesenchymal cells in the prostate are epithelial-primed Nestin-expressing cells (EPNECs) that can generate self-renewing prostate organoids with bipotential capacity. Upon transplantation, these EPNECs can form prostate gland tissue grafts at the clonal level. Lineage-tracing analyses show that cells marked by Nestin or NG2 transgenic mice contribute to prostate epithelium during organogenesis. In the adult, modest contributions in repeated rounds of regression and regeneration are observed, whereas prostate epithelial cells derived from Nestin/NG2-marked cells are dramatically increased after severe irradiation-induced organ damage. These results indicate that Nestin/NG2 expression marks a novel radioresistant prostate stem cell that is active during development and displays reserve stem cell activity for tissue maintenance.
Assuntos
Antígenos/biossíntese , Células Epiteliais/metabolismo , Nestina/biossíntese , Transplante de Órgãos , Próstata/metabolismo , Próstata/transplante , Proteoglicanas/biossíntese , Lesões Experimentais por Radiação , Tolerância a Radiação , Células-Tronco/metabolismo , Animais , Antígenos/genética , Células Epiteliais/patologia , Regulação da Expressão Gênica/efeitos da radiação , Masculino , Camundongos , Camundongos Transgênicos , Nestina/genética , Próstata/patologia , Proteoglicanas/genética , Lesões Experimentais por Radiação/metabolismo , Lesões Experimentais por Radiação/patologia , Lesões Experimentais por Radiação/cirurgia , Células-Tronco/patologiaRESUMO
Prostate cancer is a common disease in older men. Rodent models have demonstrated that an early and later-life exposure to estrogen can lead to cancerous lesions and implicated hormonal dysregulation as an avenue for developing future prostate neoplasia. This study utilizes a human fetal prostate xenograft model to study the role of estrogen in the progression of human disease. Histopathological lesions were assessed in 7-, 30-, 90-, 200-, and 400-day human prostate xenografts. Gene expression for cell cycle, tumor suppressors, and apoptosis-related genes (ie, CDKN1A, CASP9, ESR2, PTEN, and TP53) was performed for 200-day estrogen-treated xenografts. Glandular hyperplasia was observed in xenografts given both an initial and secondary exposure to estradiol in both 200- and 400-day xenografts. Persistent estrogenic effects were verified using immunohistochemical markers for cytokeratin 10, p63, and estrogen receptor α. This model provides data on the histopathological state of the human prostate following estrogenic treatment, which can be utilized in understanding the complicated pathology associated with prostatic disease and early and later-life estrogenic exposures.
Assuntos
Modelos Animais de Doenças , Estradiol/farmacologia , Xenoenxertos/efeitos dos fármacos , Próstata/transplante , Neoplasias da Próstata/etiologia , Animais , Progressão da Doença , Estradiol/efeitos adversos , Expressão Gênica/efeitos dos fármacos , Xenoenxertos/embriologia , Xenoenxertos/patologia , Humanos , Masculino , Próstata/efeitos dos fármacos , Próstata/embriologia , Próstata/metabolismo , Hiperplasia Prostática/induzido quimicamente , Hiperplasia Prostática/etiologia , Hiperplasia Prostática/patologia , Neoplasias da Próstata/induzido quimicamente , Neoplasias da Próstata/patologia , Ratos Nus , Testosterona/efeitos adversos , Testosterona/farmacologiaRESUMO
Branching morphogenesis is thought to be governed by epithelial-stromal interactions, but the mechanisms underlying specification of branch location remain largely unknown. Prompted by the striking absence of Hedgehog (Hh) response at the sites of nascent buds in regenerating tubules of the adult prostate, we investigated the role of Hh signalling in adult prostate branching morphogenesis. We find that pathway activity is localized to stromal cells, and that its attenuation by genetic or pharmacologic manipulation leads to increased branching. Decreased pathway activity correlates with increased stromal production of hepatocyte growth factor (Hgf), and we show that Hgf induces epithelial tubule branching. Regulation of Hgf expression by Hh signalling is indirect, mediated by Hh-induced expression of the microRNAs miR-26a and miR-26b, which in turn downregulate expression of Hgf. Prostate tubule branching thus may be initiated from regions of low Hh pathway activity, with implications for the prostatic hyperplasia commonly observed in late adulthood.
Assuntos
Proteínas Hedgehog/genética , Fator de Crescimento de Hepatócito/genética , MicroRNAs/genética , Morfogênese , Próstata/crescimento & desenvolvimento , Regiões 3' não Traduzidas/genética , Animais , Castração , Cães , Regulação para Baixo , Antagonistas de Estrogênios/farmacologia , Células HEK293 , Fator de Crescimento de Hepatócito/biossíntese , Humanos , Fatores de Transcrição Kruppel-Like/biossíntese , Células Madin Darby de Rim Canino , Masculino , Camundongos , Camundongos Transgênicos , MicroRNAs/biossíntese , Morfolinas/farmacologia , Próstata/citologia , Próstata/transplante , Hiperplasia Prostática/genética , Hiperplasia Prostática/patologia , Purinas/farmacologia , RNA Mensageiro/genética , Regeneração/genética , Regeneração/fisiologia , Transdução de Sinais , Células Estromais/metabolismo , Tamoxifeno/farmacologia , Testosterona/administração & dosagem , Testosterona/biossíntese , Testosterona/farmacologia , Proteína GLI1 em Dedos de ZincoRESUMO
Wnt signaling is crucial for a variety of biological processes, including body axis formation, planar polarity, stem cell maintenance and cellular differentiation. Therefore, targeted manipulation of Wnt signaling in vivo would be extremely useful. By applying chemical inducer of dimerization (CID) technology, we were able to modify the Wnt co-receptor, low-density lipoprotein (LDL)-receptor-related protein 5 (LRP5), to generate the synthetic ligand inducible Wnt switch, iLRP5. We show that iLRP5 oligomerization results in its localization to disheveled-containing punctate structures and sequestration of scaffold protein Axin, leading to robust ß-catenin-mediated signaling. Moreover, we identify a novel LRP5 cytoplasmic domain critical for its intracellular localization and casein kinase 1-dependent ß-catenin signaling. Finally, by utilizing iLRP5 as a Wnt signaling switch, we generated the Ubiquitous Activator of ß-catenin (Ubi-Cat) transgenic mouse line. The Ubi-Cat line allows for nearly ubiquitous expression of iLRP5 under control of the H-2K(b) promoter. Activation of iLRP5 in isolated prostate basal epithelial stem cells resulted in expansion of p63(+) cells and development of hyperplasia in reconstituted murine prostate grafts. Independently, iLRP5 induction in adult prostate stroma enhanced prostate tissue regeneration. Moreover, induction of iLRP5 in male Ubi-Cat mice resulted in prostate tumor progression over several months from prostate hyperplasia to adenocarcinoma. We also investigated iLRP5 activation in Ubi-Cat-derived mammary cells, observing that prolonged activation results in mammary tumor formation. Thus, in two distinct experimental mouse models, activation of iLRP5 results in disruption of tissue homeostasis, demonstrating the utility of iLRP5 as a novel research tool for determining the outcome of Wnt activation in a precise spatially and temporally determined fashion.
Assuntos
Homeostase , Proteína-5 Relacionada a Receptor de Lipoproteína de Baixa Densidade/metabolismo , Multimerização Proteica , Via de Sinalização Wnt , Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Sequência de Aminoácidos , Animais , Proteína Axina/metabolismo , Caseína Quinase I/metabolismo , Proteínas Desgrenhadas , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Feminino , Humanos , Espaço Intracelular/metabolismo , Masculino , Neoplasias Mamárias Animais/patologia , Microdomínios da Membrana/metabolismo , Camundongos , Dados de Sequência Molecular , Fosfoproteínas/metabolismo , Fosforilação , Próstata/patologia , Próstata/transplante , Ligação Proteica , Transporte Proteico , Células Estromais/metabolismo , Células Estromais/patologia , Relação Estrutura-Atividade , Proteínas Supressoras de Tumor/metabolismo , beta Catenina/metabolismoRESUMO
BACKGROUND: Recombinant xenografts of human cells growing in immunocompromised rodents are widely used for studying stem cell biology, tumor biology, and epithelial to mesenchyme transitions. Of critical importance is the correct interpretation of the cellular composition of such xenografts. METHODS: Here we present a rapid and robust method employing protein nucleic acid (PNA) FISH probes to dual-label centromeres and telomeres (Cen/Tel FISH). Such labeling allows unambiguous discrimination between human, mouse, and rat cells in paraffin-embedded tissue sections, providing significant advantages over current methods used to discern human versus rodent cell types. RESULTS: Using an in vivo prostatic developmental system where rat embryonic urogenital sinus mesenchyme is recombined with human prostate epithelial organoids and grown in an immunocompromised mouse, Cen/Tel FISH documents that all three species contribute to the development of glandular structures. CONCLUSIONS: The method is an indispensable tool to analyze xenograft/host interactions and prevent misinterpretation of data using tissue recombination approaches.
Assuntos
Hibridização in Situ Fluorescente/métodos , Próstata/citologia , Próstata/transplante , Transplante Heterólogo/métodos , Animais , Biomarcadores , Biópsia , Separação Celular/métodos , Centrômero/genética , Epitélio/embriologia , Epitélio/transplante , Feminino , Humanos , Hospedeiro Imunocomprometido , Masculino , Mesoderma/citologia , Mesoderma/embriologia , Camundongos , Técnicas de Cultura de Órgãos/métodos , Inclusão em Parafina , Gravidez , Próstata/embriologia , Ratos , Ratos Sprague-Dawley , Proteínas Recombinantes/genética , Especificidade da Espécie , Telômero/genéticaRESUMO
Androgen deprivation causes a reduction of blood flow in the prostate gland that precedes temporally apoptosis of the epithelium. The acute response of prostate endothelial cells to androgen deprivation suggested they represent a primary target for androgen. However, rat prostate endothelial cells were reported not to express androgen receptor (AR), and the role of the androgen axis in human prostate endothelial cell (HPEC) homeostasis was poorly characterized. In this study AR expression was detected in HPEC in vivo in clinical specimens of benign prostate and prostate cancer, and AR function as a transcription factor was demonstrated in HPEC in primary xenografts of human benign prostate tissue transplanted into severe combined immunodeficient mice by iv administration of adenoviral mouse mammary tumor virus-driven luciferase expression vector. AR expression and functionality were maintained in vitro in primary cultures of HPEC that coexpressed CD31, CD34, von Willebrand factor, intercellular adhesion molecule, vascular endothelial growth factor receptor 1, and vascular endothelial growth factor receptor 2 but did not express prostate-specific antigen. AR expression in primary cultures of HPEC isolated from surgical specimens of benign prostate was validated using RT-PCR, cDNA sequencing, immunocytochemistry, and Western blot analyses. Scatchard analyses demonstrated a single ligand-binding site for R1881 in primary cultures of HPEC, with dissociation constant of 0.25 nm, and AR-mediated transcriptional activity was demonstrated using adenoviral mouse mammary tumor virus-driven luciferase reporters. Dihydrotestosterone increased proliferation in primary cultures of HPEC in a dose-dependent manner without modulating endothelial tube formation in Matrigel (BD Biosciences, Bedford, MA). Therefore, HPECs express functional AR, and androgen plays a direct role in modulating HPEC biology.
Assuntos
Células Endoteliais/fisiologia , Próstata/fisiologia , Receptores Androgênicos/fisiologia , Animais , Células Endoteliais/transplante , Endotélio Vascular/fisiologia , Homeostase , Humanos , Masculino , Camundongos , Camundongos SCID , Próstata/transplante , Ratos , Receptores Androgênicos/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transplante Heterólogo , Veias Umbilicais/fisiologiaRESUMO
The Wnt/beta-catenin signaling pathway is critical for normal mammalian development, the specification of epidermal cells and neoplastic transformation of intestinal epithelium. However, precise molecular information regarding cell-specific responses to beta-catenin signaling has been limited. This question was addressed using a mouse model in which exon 3 of the beta-catenin gene was deleted in several cell types with loxP-mediated recombination utilizing a Cre transgene under control of the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). The stabilization of beta-catenin in prostate epithelium resulted in hyperplasias and extensive transdifferentiation into epidermal-like structures, which expressed keratins 1 and 6, filaggrin, loricrin and involucrin. The cell-specific loss of NKCC1 protein and reduced nuclear Stat5a is further suggestive of a loss of prostate epithelial characteristics. In addition to the prostate, hyperplasias and squamous metaplasias were detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and salivary gland. However, and in contrast to a recent study, no lesions reminiscent of high-grade prostate intraepithelial neoplasia were detected. Since beta-catenin was activated in several cell types and impinged upon the viability of these mice, it was not possible to evaluate the cumulative effect over more than 3 months. To assess long-term consequences of beta-catenin activation, mutant and control prostate tissues were transplanted into the mammary fat pads of wild-type males. Notably, squamous metaplasias, intra-acinous hyperplasia and possible neoplastic transformation were observed after a total of 18 weeks of beta-catenin stimulation. This suggests that the transdifferentiation into squamous metaplasias is an early response of endoderm-derived cells to beta-catenin, and that the development of intra-acinous hyperplasias or neoplastic foci is a later event.
Assuntos
Proteínas do Citoesqueleto/fisiologia , Próstata/patologia , Transativadores/fisiologia , Tecido Adiposo , Animais , Antígenos de Diferenciação/análise , Biomarcadores , Diferenciação Celular , Linhagem da Célula , Transformação Celular Neoplásica/genética , Proteínas do Citoesqueleto/genética , Endoderma/citologia , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Células Epiteliais/transplante , Éxons/genética , Perfilação da Expressão Gênica , Regulação da Expressão Gênica , Hiperplasia , Masculino , Glândulas Mamárias Animais , Vírus do Tumor Mamário do Camundongo/genética , Metaplasia , Camundongos , Camundongos Transgênicos , Especificidade de Órgãos , Próstata/transplante , Proteínas Recombinantes de Fusão/fisiologia , Deleção de Sequência , Sequências Repetidas Terminais , Transativadores/genética , Transgenes , Transplante Heterotópico , beta CateninaRESUMO
BACKGROUND: Androgen deprivation induces apoptosis in the prostate. Representative data, quantitating apoptotic activity in human prostatic epithelium following androgen ablation, are lacking. METHODS: Human prostatic tissue was grafted beneath the renal capsule of intact male athymic mice and allowed to become established. The mice were castrated and specimens were harvested on post-castration day 0, 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 17, 18, and 21. Tissue was immediately fixed and apoptotic epithelial nuclei were identified. RESULTS: The percentage of terminal deoxynucleotidyl-transferase-mediated dUTP nick end-labeling (TUNEL) positive epithelial cells increased from a baseline of 0.026%, peaked on post-castration day 3 (1.54%), and returned to baseline by day 21. Mathematical analysis predicted that the observed apoptotic activity account for the loss of 87% of prostatic epithelial cells in 3 weeks. CONCLUSIONS: Post-castration apoptosis in human prostatic epithelium was low but was sufficient to account for the loss of nearly 90% of epithelial cells.
Assuntos
Apoptose , Orquiectomia , Próstata/patologia , Próstata/transplante , Androgênios/deficiência , Animais , Células Epiteliais/patologia , Humanos , Marcação In Situ das Extremidades Cortadas , Masculino , Camundongos , Camundongos Nus , Transplante HeterólogoRESUMO
Osteoblastic metastases are common in patients with advanced prostate cancer. The pathophysiology of the new bone formation at metastatic sites is not currently known, but it is hypothesized that growth factors secreted by the prostate may be involved. Unfortunately, most rodent models of prostate cancer with metastasis to bone are osteolytic and not osteoblastic. Significant osteolysis by tumor cells at metastatic sites also may lead to fractures or bone instability. Misinterpretation of new periosteal bone due to bone instability as tumor-cell osteo-induction is another disadvantage of the osteolytic models. To circumvent these problems, we have developed a model system of new bone formation in the calvaria of nude mice stimulated by normal canine prostate tissue. Collagenase-digested normal prostate tissue was implanted adjacent to the calvaria of nude mice. Calvaria were examined at 2 weeks post-implantation for changes in the bone microenvironment by histology, calcein uptake at sites of bone mineralization, and tartrate-resistant acid phosphatase staining for osteoclasts. The prostate tissue remained viable and induced abundant new woven bone formation on the adjacent periosteal surface. In some cases new bone formation also was induced on the distant or concave calvarial periosteum. The new bone stained intensely with calcein, which demonstrated mineralization of the bone matrix. The new bone formation on prostate-implanted calvaria significantly increased (1.7-fold) the thickness of the calvaria compared with control calvaria. New bone formation was not induced in calvaria of mice implanted with normal canine kidney, urinary bladder, spleen, or skeletal muscle tissue, or mice with surgically-induced disruption of the periosteum. Osteoclast numbers in the medullary spaces and periosteum of calvaria were mildly increased (61%) in mice with implanted prostate tissue. In conclusion, this animal model will be useful for investigating the roles of prostate-derived growth factors on new bone formation in vivo.
Assuntos
Cães , Osteogênese , Próstata/metabolismo , Crânio/fisiologia , Fosfatase Ácida/metabolismo , Animais , Calcificação Fisiológica , Fluoresceínas/metabolismo , Humanos , Isoenzimas/metabolismo , Masculino , Camundongos , Camundongos Nus , Osteoclastos , Próstata/transplante , Crânio/citologia , Fosfatase Ácida Resistente a Tartarato , Transplante de Tecidos , Transplante HeterólogoRESUMO
Human tissue xenograft models are currently the only tool for conducting in vivo analyses of intact human tissue. The goal of the present study was to develop reliable methods for successful generation of short-term primary tissue xenografts from benign and tumor-derived human prostate tissue. Primary human prostate xenografts were established in athymic nu/nu mice from eight of eight benign and five of five prostate cancer tissues, collected from a total of 10 patients who underwent radical prostatectomy for the treatment of prostate cancer. An average of 13 xenografts was established per specimen. Two tissue specimens were cryopreserved for >1 month before successful generation of prostate xenografts. After 1 month in vivo, xenograft tissues were harvested and examined regarding: gross evidence of vascularization; tissue morphology; proliferation; apoptosis; and expression of androgen receptor, prostate-specific antigen, and high molecular weight cytokeratins specific for basal cells in the prostate. Direct comparison of the original tissue specimen and the 1-month xenografts revealed similar histology; similar apoptotic and proliferative fractions in most cases; and comparable expression levels and expression patterns of androgen receptor, prostate-specific antigen, and high molecular weight cytokeratins. These data demonstrate that primary human prostate xenografts, benign and malignant, can be established routinely from human prostate tissue surgical specimens, and that the xenografts maintain tissue architecture and expression of key prostatic markers. The development of this methodology, including the technique for cryopreservation of human tissue, will allow multiple (successive) analyses of human prostate tissue to be conducted throughout time using a tissue sample derived from a single patient; and simultaneous analysis of human prostate tissues derived from a cohort of patients.
Assuntos
Transplante de Neoplasias , Patologia/métodos , Próstata/fisiologia , Próstata/transplante , Neoplasias da Próstata/patologia , Neoplasias da Próstata/fisiopatologia , Transplante Heterólogo , Animais , Humanos , Masculino , Camundongos , Camundongos Nus , Próstata/patologia , Próstata/fisiopatologia , Fatores de TempoRESUMO
Normal adult prostate epithelium of both human and rat origin was transplanted with Matrigel into intact or androgen-ablated (i.e., castrated) nude mice. Within these transplants, an influx of mouse mesenchymal cells was one of the earliest events to occur resulting in the development of a collar of smooth muscle cells and fibroblasts surrounding the transplanted epithelium. A subset of these surrounding stromal cells express androgen receptor (AR). The surrounded transplanted epithelium initially expresses high molecular weight cytokeratins characteristic of prostatic basal cells and AR. In both intact and androgen-ablated hosts, this epithelium subsequently develops a patent lumen producing a rudimentary glandular acini. Only in the nonablated hosts, however, do these rudimentary acini undergo a further proliferative growth phase, as determined by Ki67 immunocytochemical stainings and the development of a low molecular weight cytokeratin positive layer of luminal (i.e., secretory) epithelial cells. Because AR is expressed in both the donor epithelium and host (i.e., mouse) stromal cells, this androgen-stimulated growth response could involve either autocrine pathways initiated within donor normal adult epithelial cells themselves or paracrine pathways initiated within the AR-expressing subset of mouse stromal cells. To resolve this issue, mice carrying the testicular feminized mutation in the X-linked AR gene were cross-bred to AR-wt nude mice to produce AR-null nude male mice. None of the cells in these AR-null nude male mice express functional AR protein. Therefore, these animals can be used to prevent any possibility of host stromal cell paracrine involvement in initiating an androgen-stimulated growth response when normal adult or malignant prostatic epithelial cells are transplanted into these null hosts. In these AR-null nude male mice, the androgen-stimulated growth of normal adult prostatic epithelial cells did not occur (i.e., androgen-induced growth response of normal prostatic epithelial cells requires stromal cell paracrine involvement). In contrast, using four different prostatic cancer models (i.e., human PC-82, human LNCaP, human LAPC-4, and rat R3327G), the androgen-stimulated growth of prostatic cancer cells occurred identically in both AR-null and AR-wt nude male mice (i.e., a direct autocrine mechanism is responsible for androgen-stimulated growth of malignant prostatic epithelial cells). In summary, a fundamental change in the mechanism for androgen-stimulated growth occurs during the transformation from normal to malignant prostatic epithelial cells.
Assuntos
Androgênios/fisiologia , Transformação Celular Neoplásica/patologia , Próstata/patologia , Neoplasias da Próstata/patologia , Animais , Divisão Celular/fisiologia , Transplante de Células , Células Epiteliais/patologia , Humanos , Masculino , Camundongos , Camundongos Nus , Orquiectomia , Próstata/transplante , Hiperplasia Prostática/patologia , Ratos , Receptores Androgênicos/biossíntese , Receptores Androgênicos/fisiologia , Testosterona/sangue , Transplante HeterólogoRESUMO
BACKGROUND: Neuroendocrine (NE) cells and nerves in the prostate gland are thought to play a central role in the regulation of growth, cellular differentiation and homeostasis of secretory activity. The objective of this experimental study was to describe the effects of peripheral denervation and castration on NE cells and nerves in the guinea pig prostate. METHODS: Guinea pigs underwent sham-operation, unilateral and bilateral hypogastric nerve resection, extirpation of the right anterior major pelvic ganglion (AMPG), autotransplantation of prostatic tissue and castration. Cryostat sections of prostatic tissue were examined with immunohistochemistry by using serotonin (5-HT) and chromogranin A (CgA) and various neuropeptides. RESULTS: The number of 5-HT-IR NE cells was four-fold higher than CgA-IR NE cells. The innervation pattern was uniform throughout the gland with subepithelial nerves in close proximity to NE cells. Autotransplants of prostatic tissue showed total loss of nerves, but the number and morphology of 5-HT-IR NE cells were unaltered. Extirpation of the right AMPG showed significant reduction in prostate weight, decreased density of nerve terminals in the superior part of the ipsilateral prostate, whereas the number and morphological feature of 5-HT-IR NE cells remained unaffected in the entire prostate. Castration induced atrophy of the gland with a significant reduction in weight (unpaired t-test, P < 0.001), but without effect upon 5-HT-IR NE cells. CONCLUSIONS: The guinea pig seems to be a useful animal model for studies on the role of the NE cells in the prostate. NE cells seem to be independent of innervation and androgens. It seems that other factors influence the NE cell population to a greater extent.
Assuntos
Denervação Autônoma , Sistemas Neurossecretores/fisiologia , Orquiectomia , Próstata/inervação , Animais , Cromogranina A , Cromograninas/metabolismo , Gânglios Autônomos/fisiologia , Gânglios Autônomos/cirurgia , Cobaias , Plexo Hipogástrico/fisiologia , Plexo Hipogástrico/cirurgia , Imuno-Histoquímica , Masculino , Sistemas Neurossecretores/citologia , Sistemas Neurossecretores/metabolismo , Próstata/citologia , Próstata/transplante , Serotonina/metabolismoRESUMO
Human prostate tissue transplanted into nude mice was examined immunohistochemically for DNA adducts formed after administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Positive staining for DMAB- or PhIP-DNA adducts was evident in 70-95% of both epithelial and stromal cells in human prostate xenografts. Reverse transcription-polymerase chain reaction (RT-PCR) analysis revealed a normal human prostate epithelial cell line (PrEC) to express both cytochrome P450 1A2 (CYP1A2) and N-acetyltransferase 2 (NAT2) mRNA, while a normal human prostate fibroblast cell line (NHPF) expressed NAT2, but not CYP1A2 mRNA. In addition, NAT2 and to a lesser extent CYP1A2 mRNAs were also found in four cases of normal human prostate tissues. The results suggest that initial activation of chemicals by liver CYP1A2 and subsequent metabolism by prostate NAT2 is a major pathway of DNA adduct formation in human prostate cells. Thus, the data suggest that human prostate has the potential to be targeted by environmental carcinogens.
Assuntos
Compostos de Aminobifenil/farmacologia , Arilamina N-Acetiltransferase/metabolismo , Carcinógenos/farmacologia , Citocromo P-450 CYP1A2/metabolismo , Adutos de DNA/biossíntese , Imidazóis/farmacologia , Próstata/metabolismo , Idoso , Animais , Linhagem Celular , Adutos de DNA/análise , Células Epiteliais/metabolismo , Células Epiteliais/patologia , Humanos , Imuno-Histoquímica , Masculino , Camundongos , Camundongos Nus , Pessoa de Meia-Idade , Próstata/efeitos dos fármacos , Próstata/transplante , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
BACKGROUND: The clonally derived rat prostatic epithelial cell line NRP-152 was examined to determine its ability to differentiate in a tissue recombination model. METHODS: NRP-152 cells alone, or combined with urogenital mesenchyme (UGM) or 10T1/2 fibroblasts, were grafted beneath the renal capsule of athymic rodent hosts. After 1 and 3 months, grafts were examined grossly and immunohistochemically. RESULTS: NRP-152 cells grafted alone formed small (10-25 mg) grafts without recognizable architecture. NRP-152 cells recombined with UGM formed larger grafts (50-100 mg after 28 days) containing glandular epithelium. Columnar luminal cells expressed cytokeratins 8 and 18 and rat prostatic secretory markers (DP-1 and DP-2). The epithelial ducts were surrounded by well-differentiated smooth muscle. The glandular epithelial cells were shown to be of rat origin. NRP-152 + 10T1/2 tissue recombinants formed small grafts (10-40 mg wet weight) after 1 month. The epithelial component of these grafts formed solid unbranched cords expressing cytokeratins 5 and 14; no glandular epithelial structures were observed. The stromal matrix was densely packed with a few cells expressing alpha-actin. CONCLUSIONS: A clonally derived prostatic epithelial cell line can form structurally and functionally normal prostatic tissue. This suggests that prostatic basal and luminal epithelial cells can be derived from a common progenitor.
Assuntos
Comunicação Celular , Próstata/transplante , Animais , Diferenciação Celular , Linhagem Celular , Células Epiteliais/citologia , Células Epiteliais/transplante , Fibroblastos/citologia , Fibroblastos/transplante , Masculino , Mesoderma/citologia , Mesoderma/transplante , Camundongos , Camundongos Nus , Próstata/citologia , Ratos , Células Estromais/citologia , Células Estromais/transplante , Transplante HeterólogoRESUMO
BACKGROUND: Prostate tumors are characterized by sex hormone-associated growth and mesenchymal-epithelial interactions. This study was conducted to establish an ex vivo system where human prostate tissue could be maintained for a certain period under conditions resembling the in vivo situation in man to provide an experimental tool for investigation of prostate disease. METHODS: Human prostate tissues (peripheral zone and transition zone) obtained by total cystectomy were transplanted into the subcutis of male KSN nude mice for up to 24 weeks without exogenous hormonal manipulation. RESULTS: Transplants could be maintained, and although they showed several histological alterations, such as cystic dilation, basal-cell hyperplasia, and squamous-cell metaplasia, many retained a nearly normal appearance for the entire 24-week duration. Immunohistochemically, androgen receptors were strongly positive in the nuclei of glandular epithelial cells. Prostate-specific antigen (PSA) and prostatic acid phosphate (PAP) (both from DAKO, Glostrup, Denmark), were also expressed in the cytoplasm. The proportion of cells expressing proliferating cell nuclear antigen (PCNA) was not related to the period of transplantation and did not differ between the peripheral and transition zones. CONCLUSIONS: The results clearly demonstrate that human prostate tissues transplanted into nude mice can maintain their morphological and biological characteristics for up to 24 weeks. This provides a simple and useful tool for basic research into human prostate neoplasia.
Assuntos
Próstata/transplante , Receptores Androgênicos/fisiologia , Transplante Heterólogo/patologia , Animais , Humanos , Hiperplasia , Imuno-Histoquímica , Masculino , Metaplasia , Camundongos , Camundongos Nus , Antígeno Nuclear de Célula em Proliferação/análise , Próstata/patologia , Antígeno Prostático Específico/metabolismoRESUMO
A new method of treatment planning for the I-125 and Pd-103 permanent interstitial prostate implant is developed, which does not use the traditional nomograms but automatically generates optimized source configurations. An iterative algorithm is used that places one seed at a step. The volume dose of target is calculated at each step to determine the coldest spot where the next source is to be placed, so that the dose uniformity of target is best improved as source placement proceeds. At each step, the total activity required for the seed configuration as so established is calculated by normalizing the minimal dose to the prescribed dose. An optimized configuration is the one that takes the minimized total activity. Around its minimum the total activity has a very small variation with the number of seeds. Consequently multiple clinically acceptable seed configurations with similar total activity but different individual activities are generated simultaneously. In our computer generated treatment plans most of the seeds are distributed in the periphery of the target, similar to the Paterson-Parker pattern of a volume implant.
Assuntos
Próstata/transplante , Dosagem Radioterapêutica , Planejamento da Radioterapia Assistida por Computador , Humanos , MasculinoRESUMO
Basic studies on the pathogenesis of prostate disease including hypertrophy and cancer have been difficult due to the lack of suitable animal models. Much effort has been directed to the development of appropriate animal models, and yet many obstacles still remain. Rodents do not develop spontaneous hypertrophy of the prostate, in fact the prostate atrophies with advancing age. Guinea pigs appear to be a good model to study the effect of hormones on the prostate gland. Microinvasive prostatic adenocarcinoma occurs spontaneously in various species of rodents, and can be induced by radiation, hormones and chemical carcinogens. The man and dog appear to be the only mammals which suffer naturally from the pathological processes of the prostate gland associated with aging. We review the currently available models for the study of benign, and malignant prostate disease and assess the strengths and weaknesses each for preclinical investigations.
Assuntos
Adenocarcinoma/patologia , Modelos Animais de Doenças , Hiperplasia Prostática/patologia , Neoplasias da Próstata/patologia , Adenocarcinoma/etiologia , Animais , Cricetinae , Cães , Feminino , Cobaias , Humanos , Masculino , Camundongos , Camundongos Nus , Próstata/anatomia & histologia , Próstata/transplante , Hiperplasia Prostática/etiologia , Neoplasias da Próstata/etiologia , Ratos , Ratos Wistar , Especificidade da Espécie , Transplante HeterólogoRESUMO
Carcinomas of the prostate and other lineages often present an autocrine stimulatory loop acting via the EGF receptor (EGFR). We have recently shown that EGFR-mediated signals enhance DU-145 prostate carcinoma cell transmigration of an extracellular matrix in vitro, and that this increased invasiveness was independent of proteolytic degradation of the matrix (Xie et al., 1995, Clin Exp Metastasis, 13, 407). To determine whether up-regulated EGFR signaling promotes tumor progression in vivo and to define the EGFR-induced cell property responsible, we inoculated athymic mice with genetically-engineered DU-145 cells. Parental DU-145 cells and those transduced to overexpress a full-length wild type (WT) EGFR formed tumors and metastasized to the lung when inoculated in the prostate and peritoneal cavity. The WT DU-145 tumors were more invasive. DU-145 cells expressing a mitogenically-active, but motility-deficient (c'973) EGFR formed small, non-invasive tumors without evidence of metastasis. All three sublines demonstrated identical, EGFR-dependent rates of cell growth in vitro, suggesting that the differential invasiveness was not due to altered growth rates. To determine whether cell motility may be, in part, responsible for tumor invasiveness, we treated WT DU-145 intraperitoneal tumors with a pharmacologic agent (U73122) which blocks EGFR-mediated cell motility but not mitogenesis. Under this treatment regimen, the WT DU-145 cells formed tumors of similar numbers and size to those formed without treatment; however, these tumors were much less invasive. These data suggest that EGFR-mediated cell motility is an important mechanism involved in tumor progression, and that this cell property may represent a novel target to limit the spread of tumors.